Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P23193 (
transcription elongation factor
)
739
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
RNA polymerase II is unable to bypass bulky DNA lesions induced by agents like ultraviolet light (UV light) and cisplatin that are located in the template strand of active genes. Arrested polymerases form a stable ternary complex at the site of DNA damage that is thought to pose an impediment to the repair of these lesions. Transcription-coupled nucleotide excision repair (TC-NER) preferentially repairs these DNA lesions through an incompletely defined mechanism. Based on elegant in vitro experiments, it was hypothesized that the
transcription elongation factor IIS
(
TFIIS
) may be required to couple transcription to repair by catalyzing the reverse translocation of the arrested polymerase, allowing access of repair proteins to the site of DNA damage. However the role of
TFIIS
in this repair process has not been tested in vivo. Here, silencing
TFIIS
using an RNA interference strategy did not affect the ability of cells to recover nascent RNA synthesis following UV exposure or the ability of cells to repair a UV-damaged reporter gene while a similar strategy to decrease the expression
Cockayne syndrome group B protein
(
CSB
) resulted in the expected repair defect. Furthermore, RNA interference against
TFIIS
did not increase the sensitivity of cells to UV light or cisplatin while decreased expression of
CSB
did. Taken together, these results indicate that
TFIIS
is not limiting for the repair of transcription-blocking DNA lesions and thus the present work does not support a role for
TFIIS
in TC-NER.
...
PMID:RNA interference against transcription elongation factor SII does not support its role in transcription-coupled nucleotide excision repair. 2107 Jul 92